ROMIPLOSTIM INJ,LYPHL
Clinical Criteria Summary
Exclusion Criteria
- Stem cell disorder (i.e. myelodysplastic syndrome)
- Patient has not received prior therapy with steroids to increase platelet counts
- Thrombocytopenia secondary to bone marrow suppressive anti-cancer therapy, antibiotics, or other drugs
- Thromboembolic events within the past year (unless evaluated by a hematology provider and deemed an appropriate candidate)
- Pregnancy and/or breastfeeding
Inclusion Criteria
- Diagnosis of chronic Immune Thrombocytopenia (ITP)
- Platelet count < 30,000 mm3 and/or persistent bleeding resistant/refractory to glucocorticoids
- Relapse after second-line therapies (unless contraindicated or patient is not a candidate):
- Splenectomy
- Rituximab
- For patients who can become pregnant: Counseling provided on potential risks vs. benefits of taking drug if patient were to become pregnancy; advise patients not to breastfeed during treatment